XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.3
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION - Schedule of Disaggregation of Total Net Product Revenues by Product (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue from External Customer [Line Items]        
Revenue $ 745,740 $ 581,329 $ 2,106,602 $ 1,773,019
Product        
Revenue from External Customer [Line Items]        
Revenue 733,867 568,266 2,073,811 1,739,390
VOXZOGO        
Revenue from External Customer [Line Items]        
Revenue 189,785 122,973 526,597 324,146
VIMIZIM        
Revenue from External Customer [Line Items]        
Revenue 178,158 158,869 548,694 525,453
NAGLAZYME        
Revenue from External Customer [Line Items]        
Revenue 131,906 108,916 369,584 322,040
PALYNZIQ        
Revenue from External Customer [Line Items]        
Revenue 90,634 78,885 254,634 216,105
ALDURAZYME        
Revenue from External Customer [Line Items]        
Revenue 71,029 13,812 144,849 88,533
BRINEURA        
Revenue from External Customer [Line Items]        
Revenue 37,005 41,042 121,361 118,244
KUVAN        
Revenue from External Customer [Line Items]        
Revenue 28,115 42,947 92,576 144,047
ROCTAVIAN        
Revenue from External Customer [Line Items]        
Revenue 7,235 822 15,516 822
Royalty and other revenues        
Revenue from External Customer [Line Items]        
Revenue $ 11,873 $ 13,063 $ 32,791 $ 33,629